![Ian Osterloh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ian Howard Osterloh is the founder of Ixchelsis Ltd., founded in 2011, and held the title of Chief Medical Officer from 2011 to 2013.
Former jobs include Chief Marketing Officer at PregLem SA and Principal at Pfizer (St. Louis).
Education history includes a doctorate from the University of London and undergraduate and graduate degrees from the University of Bristol.
Anciens postes connus de Ian Osterloh
| Sociétés | Poste | Fin |
|---|---|---|
Ixchelsis Ltd.
 Ixchelsis Ltd. BiotechnologyHealth Technology Develops oxytocin receptor antagonist for the treatment of premature ejaculation | Fondateur | 18/07/2013 |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Corporate Officer/Principal | - |
PregLem SA
 PregLem SA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health | Sales & Marketing | - |
Formation de Ian Osterloh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health | Health Technology |
Ixchelsis Ltd.
Ixchelsis Ltd. BiotechnologyHealth Technology Develops oxytocin receptor antagonist for the treatment of premature ejaculation | Health Technology |
